The ExAblate® system was the first system to use the MR guided focused ultrasound technology that combines MRI – to visualize the body anatomy, plan the treatment and monitor treatment outcome in real time and high intensity focused ultrasound to thermally ablate tumors inside the body non-invasively. MR thermometry allows the physician to control and adjust the treatment in real time to ensure that the targeted tissue is treated and surrounding non targeted tissue is spared.

The ExAblate® received CE mark in 2002 and the Food and Drug Administration (FDA) approval in 2004 for the treatment of symptomatic uterine fibroids. ExAblate® received the European CE Mark for pain palliation of bone metastases in June 2007 and for adenomyosis in June 2010. This device has won numerous innovation awards and has been used to treat thousands of patients around the world.

MAKOplasty® is powered by the RIO® Robotic Arm Interactive Orthopedic System, a highly advanced robotic arm technology that assists your orthopedic surgeon in achieving consistently reproducible precision for the individual patient in knee and hip joint replacement.

MAKOplasty® Partial Knee Resurfacing is an innovative treatment option designed to relieve pain and restore range of motion for adults living with early to mid-stage osteoarthritis that has not progressed to all three compartments of the knee.

MAKOplasty® Total Hip Arthroplasty, is a new RIO® robotic arm application for those in need of total hip replacement. Advanced robotic arm technology and versatile implants assist surgeons in attaining a new level of accuracy and precision designed to restore mobility and active lifestyle.